Vyvanse and Brexpiprazole drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Vyvanse (lisdexamfetamine dimesylate) and Brexpiprazole (brexpiprazole). Common drug interactions include fatigue among females and agitation among males.
The phase IV clinical study analyzes what interactions people have when they take Vyvanse and Brexpiprazole. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.
What is Vyvanse?
Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,872 Vyvanse users. Check the latest studies of Vyvanse.
What is Brexpiprazole?
Brexpiprazole has active ingredients of brexpiprazole. eHealthMe is studying from 1,164 Brexpiprazole users. Check the latest studies of Brexpiprazole.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
13 people who take Vyvanse and Brexpiprazole together, and have interactions are studied.

What are the common drug interactions of Vyvanse and Brexpiprazole, by gender? *:
female:
- Fatigue (feeling of tiredness)
- Insomnia (sleeplessness)
- Restlessness (not able to rest)
- Anxiety
- Decreased interest
- Depressed mood
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Weight increased
- Akathisia (a movement disorder characterized by a feeling of inner restlessness)
- Cough
male:
- Agitation (state of anxiety or nervous excitement)
- Antisocial behaviour
- Headache (pain in head)
- Antidepressant drug level below therapeutic
- Arthralgia (joint pain)
- Death
- Hunger
- Myalgia (muscle pain)
- Nausea (feeling of having an urge to vomit)
- Weight increased
What are the common drug interactions of Vyvanse and Brexpiprazole, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Agitation (state of anxiety or nervous excitement)
- Antisocial behaviour
20-29:
- Akathisia (a movement disorder characterized by a feeling of inner restlessness)
- Cough
- Fatigue (feeling of tiredness)
- Growing pains (child sometimes wake up crying in the middle of the night complaining of throbbing leg pain)
- Hypersensitivity
- Insomnia (sleeplessness)
- Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
- Nasopharyngitis (inflammation of the nasopharynx)
- Pneumonia
- Restlessness (not able to rest)
30-39:
n/a
40-49:
- Anxiety
- Decreased interest
- Depressed mood
- Fatigue (feeling of tiredness)
- Insomnia (sleeplessness)
- Restlessness (not able to rest)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Weight increased
- Antidepressant drug level below therapeutic
- Arthralgia (joint pain)
50-59:
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Fall
- Death
- Headache (pain in head)
- Infusion related reaction
- Pain
- Red blood cell sedimentation rate increased
- Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
- Weight bearing difficulty (difficulty due to weight of thigh fat deposition)
- Fatigue (feeling of tiredness)
60+:
n/a
What are the existing conditions these people have? *
- Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 5 people, 38.46%
- Stress And Anxiety: 4 people, 30.77%
- Mood Swings (an extreme or rapid change in mood): 2 people, 15.38%
- Immunodeficiency Common Variable: 2 people, 15.38%
- Depression: 2 people, 15.38%
- Trichotillomania (the compulsive urge to pull out (and in some cases, eat) one's own hair leading to noticeable hair loss, distress): 1 person, 7.69%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
- Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 1 person, 7.69%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 1 person, 7.69%
- Movement - Uncontrolled Or Slow: 1 person, 7.69%
* Approximation only. Some reports may have incomplete information.
Do you take Vyvanse and Brexpiprazole?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Vyvanse (35,872 reports)
- Brexpiprazole (1,164 reports)
Browse all drug interactions of Vyvanse and Brexpiprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Vyvanse:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Brexpiprazole:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Vyvanse and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Brexpiprazole and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
- Najib J, Wimer D, Zeng J, Lam KW, Romanyak N, Paige Morgan E, Thadavila A, "Review of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder", Journal of central nervous system disease, 2017 Aug .
- Maneeton N, Maneeton B, Suttajit S, Reungyos J, Srisurapanont M, Martin SD, "Exploratory meta-analysis on lisdexamfetamine versus placebo in adult ADHD", Drug design, development and therapy, 2017 Jan .
- Maneeton B, Maneeton N, Likhitsathian S, Suttajit S, Narkpongphun A, Srisurapanont M, Woottiluk P, "Comparative efficacy, acceptability, and tolerability of lisdexamfetamine in child and adolescent ADHD: a meta-analysis of randomized, controlled trials", Drug design, development and therapy, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on lisdexamfetamine dimesylate and brexpiprazole (the active ingredients of Vyvanse and Brexpiprazole, respectively), and Vyvanse and Brexpiprazole (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Restoril cause Visual Impairment? - 8 seconds ago
- Could Glucosamine cause Road Traffic Accident? - 9 seconds ago
- Drug interactions of Sinemet and Combivent - 9 seconds ago
- Could Paclitaxel cause Haemorrhoidal Haemorrhage? - 10 seconds ago
- Could Envarsus Xr cause Dyspnea? - 15 seconds ago
- Drug interactions of Ritalin La and Requip - 15 seconds ago
- Could Entresto cause Hypercholesterolaemia Aggravated? - 15 seconds ago
- Could Lasix cause Mean Cell Haemoglobin Increased? - 20 seconds ago
- Could Oxycontin cause Metastases To Lymph Nodes? - 21 seconds ago
- Could Lidocaine cause Intervertebral Disc Disorder? - 25 seconds ago